Woodman SE - Search Results

1

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.

Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Woodman SE, et al. Mol Cancer Ther. 2009 Aug;8(8):2079-85. doi: 10.1158/1535-7163.MCT-09-0459. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671763 Free PMC article.

2

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.

Quintás-Cardama A, Lazar AJ, Woodman SE, Kim K, Ross M, Hwu P. Quintás-Cardama A, et al. Among authors: woodman se. Nat Clin Pract Oncol. 2008 Dec;5(12):737-40. doi: 10.1038/ncponc1251. Epub 2008 Oct 21. Nat Clin Pract Oncol. 2008. PMID: 18936790

3

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.

Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Torres-Cabala CA, et al. Mod Pathol. 2009 Nov;22(11):1446-56. doi: 10.1038/modpathol.2009.116. Epub 2009 Aug 28. Mod Pathol. 2009. PMID: 19718013 Free PMC article.

4

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.

Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Davies MA, et al. Among authors: woodman se. Clin Cancer Res. 2009 Dec 15;15(24):7538-7546. doi: 10.1158/1078-0432.CCR-09-1985. Clin Cancer Res. 2009. PMID: 19996208 Free PMC article.

5

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

Woodman SE, Davies MA. Woodman SE, et al. Biochem Pharmacol. 2010 Sep 1;80(5):568-74. doi: 10.1016/j.bcp.2010.04.032. Epub 2010 May 8. Biochem Pharmacol. 2010. PMID: 20457136 Free PMC article. Review.

6

Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.

Gopal YN, Deng W, Woodman SE, Komurov K, Ram P, Smith PD, Davies MA. Gopal YN, et al. Among authors: woodman se. Cancer Res. 2010 Nov 1;70(21):8736-47. doi: 10.1158/0008-5472.CAN-10-0902. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959481 Free PMC article.

7

Are oncogenes sufficient to cause human cancer?

Woodman SE, Mills GB. Woodman SE, et al. Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20599-600. doi: 10.1073/pnas.1015563107. Epub 2010 Nov 17. Proc Natl Acad Sci U S A. 2010. PMID: 21084639 Free PMC article. No abstract available.

8

BAP1tism of a tumor suppressor.

Woodman SE. Woodman SE. Clin Cancer Res. 2012 Jan 15;18(2):323-5. doi: 10.1158/1078-0432.CCR-11-2870. Epub 2011 Dec 2. Clin Cancer Res. 2012. PMID: 22140212

9

Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition.

Deng W, Gopal YN, Scott A, Chen G, Woodman SE, Davies MA. Deng W, et al. Among authors: woodman se. Pigment Cell Melanoma Res. 2012 Mar;25(2):248-58. doi: 10.1111/j.1755-148X.2011.00950.x. Epub 2012 Jan 12. Pigment Cell Melanoma Res. 2012. PMID: 22171948

10

New strategies in melanoma: molecular testing in advanced disease.

Woodman SE, Lazar AJ, Aldape KD, Davies MA. Woodman SE, et al. Clin Cancer Res. 2012 Mar 1;18(5):1195-200. doi: 10.1158/1078-0432.CCR-11-2317. Epub 2012 Jan 24. Clin Cancer Res. 2012. PMID: 22275506 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters